Effects of low carbohydrate diet compared to low fat diet on reversing the metabolic syndrome, using NCEP ATP III criteria: a randomized clinical trial

Sherzad Ali Ismael, Sherzad Ali Ismael

Abstract

Introduction: The purpose of this study is to compare the change in the metabolic syndrome prevalence and risk factors between participants who followed a low carbohydrate diet and those who followed a low fat diet for six months in Erbil city/ Iraqi Kurdistan.

Methods: Out of 289 apparently healthy obese adults who were chosen by a stratified multistage probability sampling method, 94 of them agreed to participate in the study. They were assigned to low carbohydrate and low fat diet groups. Both groups were followed up for 6 months and the data were taken at baseline, after 3 months and after 6 months of intervention. Ninety-four obese adults completed the intervention. One-way repeated measures ANOVA was used to compare differences of metabolic dependent variables between the two independent variables, the low carbohydrate and low fat diet, at baseline, after 3 months and after 6 months of intervention.

Results: The Participants in low carbohydrate diet group had greater decrease in the prevalence of MetS. At the baseline, according to the ATP III criteria, the prevalence of metabolic syndrome was 44.4% (24/54) in low carbohydrate diet group and 60% (24/40) in low fat diet group. The prevalence of MetS was decreased significantly to 16.7% (9/54) after 3 months and to 3.7% (2/54) after 6 months in low carbohydrate diet (p < 0.001). Moreover, the prevalence of MetS was decreased significantly to 32.5 (13/40) after 3 months and to 22.5% (9/40) after 6 months in low fat diet (p < 0.001). No statistically significant difference was found between low carbohydrate diet & low fat diet at the baseline (p-value = 0.136) and after 3 months and after 6 months of intervention.

Conclusions: Both low carbohydrate diet and low fat diet have significant effects on reducing the prevalence of MetS in obese adults when followed up for 6 months. Compared to low fat diet, low carbohydrate diet had greater effect in reducing the prevalence of metabolic syndrome. Both diet programs were found to be effective in improving the metabolic state of obese adults.

Trial registration: The trial is registered retrospectively at the US National Institutes of Health ( ClinicalTrials.gov ). The registration in the US National Institutes of Health was done in 23/12/2020 with the registration number: NCT04681924 .

Keywords: Erbil; Iraq; Low carbohydrate diet; Low fat diet; Metabolic syndrome; NCEP ATP III; Reversing.

Conflict of interest statement

The author declares that there is no conflict of interest that could be perceived as prejudicing the impartially of the research reported.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Flow diagram of the progress through the phases of a parallel randomized trial of two groups
Fig. 2
Fig. 2
Prevalence of MetS from baseline, after 3 months and after 6 months of intervention in LCD & LFD groups. Standard error of the bars representing the prevalence of MetS

References

    1. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, International Diabetes Federation Task Force on Epidemiology and Prevention. Hational Heart, Lung, and Blood Institute. American Heart Association. World Heart Federation. International Atherosclerosis Society. International Association for the Study of Obesity Harmonizing the metabolic syndrome. Circulation. 2009;120(16):1640–1645. doi: 10.1161/CIRCULATIONAHA.109.192644.
    1. Kaur J. A Comprehensive Review on Metabolic Syndrome. Cardiol Res Pract. 2014;2014:21. doi: 10.1155/2014/943162.
    1. Huang PL. A comprehensive definition for metabolic syndrome. Dis Models Mechan. 2009;2(5–6):231–7. 10.1242/dmm.001180.
    1. Riccardi G, Rivellese AA. Dietary treatment of the metabolic syndrome — the optimal diet. Br J Nutri; 2000;83(S1):S143–S148, DOI: 10.1017/S0007114500001082.
    1. Lagiou P, Sandin S, Lof M, Trichopoulos D, Adami H-O, Weiderpass E. Low carbohydrate-high protein diet and incidence of cardiovascular diseases in Swedish women: prospective cohort study. BMJ (Clinical research ed) 2012;344:e4026-e. doi: 10.1136/bmj.e4026.
    1. Brehm BJ, Seeley RJ, Daniels SR, D’Alessio DA. A Randomized Trial Comparing a Very Low Carbohydrate Diet and a Calorie-Restricted Low Fat Diet on Body Weight and Cardiovascular Risk Factors in Healthy Women. J Clin Endocrinol Metab. 2003;88(4):1617–1623. doi: 10.1210/jc.2002-021480.
    1. Yancy WS, Jr, Olsen MK, Guyton JR, Bakst RP, Westman EC. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: A randomized, controlled trial. Ann Intern Med. 2004;140(10):769–777. doi: 10.1210/jc.2002-021480.
    1. Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, Wortman JA, Yancy WS, Phinney SD (2007). Low-carbohydrate nutrition and metabolism. Am. J. Clin. Nutr. (review). 86 (2): 276–284. doi:10.1093/ajcn/86.2.276. PMID 17684196.
    1. Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ, Westman EC, Accurso A, Frassetto L, Gower BA, McFarlane SI, Nielsen JV, Krarup T, Saslow L, Roth KS, Vernon MC, Volek JS, Wilshire GB, Dahlqvist A, Sundberg R, Childers A, Morrison K, Manninen AH, Dashti HM, Wood RJ, Wortman J, Worm N (2015). "Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base". Nutr (review) 31 (1): 1–13. doi:10.1016/j.nut.2014.06.011. PMID 25287761.
    1. Spritzler F. A low-carbohydrate, whole-foods approach to managing diabetes and prediabetes. Diabetes Spectrum. 2012;25(4):238–243. doi: 10.2337/diaspect.25.4.238.
    1. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American heart association nutrition committee. Circulation. 2006;114(1):82–96. doi: 10.1161/CIRCULATIONAHA.106.176158.
    1. Law M. Dietary fat and adult diseases and the implications for childhood nutrition: an epidemiologic approach. Am J Clin Nutr. 2000;72(5):1291s–1296s. doi: 10.1093/ajcn/72.5.1291s.
    1. Mansoor N, Vinknes KJ, Veierød MB, Retterstøl K. Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials. Br J Nutr. 2016;115(3):466–479. doi: 10.1017/S0007114515004699.
    1. Makris A, Foster GD. Dietary approaches to the treatment of obesity. Psychiatr Clin North Am. 2011;34(4):813–827. doi: 10.1016/j.psc.2011.08.004.
    1. Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, Bibus DM, et al. Comparison of Low Fat and Low Carbohydrate Diets on Circulating Fatty Acid Composition and Markers of Inflammation. Lipids. 2008;43(1):65–77. doi: 10.1007/s11745-007-3132-7.
    1. Organization WH. STEPS instruments for NCD risk factors (core and expanded version 1.4): the WHO STEPwise approach to Surveillance of noncommunicable diseases (STEPS). 2001.[ ].
    1. Ma WY, Yang CY, Shih SR, Hsieh HJ, Hung CS, Chiu FC, Lin MS, Liu PH, Hua CH, Hsein YC, Chuang LM, Lin JW, Wei JN, Li HY. Measurement of waist circumference: midabdominal or iliac crest? Diabetes Care. 2013;36(6):1660–1666. doi: 10.2337/dc12-1452.
    1. Ness-Abramof R, Apovian CM. Waist circumference measurement in clinical practice. Nutr Clin Pract. 2008;23(4):397–404. doi: 10.1177/0884533608321700.
    1. Mirmiran P, Asghari G, Farhadnejad H, Eslamian G, Hosseini-Esfahani F, Azizi F. Low carbohydrate diet is associated with reduced risk of metabolic syndrome in Tehranian adults. Int J Food Sci Nutr. 2017;68(3):358–365. doi: 10.1080/09637486.2016.1242119.
    1. Brinkworth GD, Noakes M, Buckley JD, Keogh JB, Clifton PM. Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo. Am J Clin Nutr. 2009;90(1):23–32. doi: 10.3945/ajcn.2008.27326.
    1. Foster GD, Wyatt HR, Hill JO, et al. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: A randomized trial. Ann Intern Med. 2010;153(3):147–157. doi: 10.7326/0003-4819-153-3-201008030-00005.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere